Haoyuan Pharmaceuticals (688131.SH): Suzhou Trust Fund plans to reduce its holdings by no more than 0.26%.

Wisdom Financial News App News, Haoyuan Pharmaceutical (688131.SH) announced that due to the expiration of the fund and the financial needs of shareholders, Suxin Fund plans to reduce its holdings of no more than 546,400 shares of the company's stock through centralized bidding, with a planned reduction ratio not exceeding 0.26% of the company's current total share capital. The reduction plan will be carried out within 3 months after the disclosure of the announcement, starting from the third trading day after the disclosure of the announcement.